- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Lupin Limited — Updates, 17-03-2026: Press Release
17-03-2026 | 12:05 pm
17-03-2026 | 12:05 pm
Lupin partnered with Zydus Lifesciences to co-market innovative Semaglutide Injection in India. This expands patient access to advanced diabetes and weight management therapies, strengthening Lupin's cardio-metabolic portfolio. Lupin will pay upfront and milestone fees.
No comments yet. Be the first to comment!